Aptar PharmaProduct InfoFirst Nasally-Administered Pharmaceutical Treatment for Dry Eye Disease Approved by US FDA with Aptar’s Nasal Pump SystemAptar Pharma’s patented Cartridge Pump System (CPS), was recently reviewed by the U.S. FDA as the dr...
Aptar PharmaProduct InfoAptar Pharma’s Nasal Unidose Device approved by US FDA for new nasal seizure rescue treatmentAptar Pharma has announced that its patented Unidose Liquid System is the device delivering a new na...
Aptar PharmaBrand LaunchNew FDA approved combination product with Aptar Pharma's VP3 nasal spray systemAptar Pharma, a global leader in drug delivery systems, services and active material science solutio...
Aptar PharmaProduct InfoAptar’s Nasal Unidose Device approved by US FDAAptarGroup, Inc, a global leader in dispensing and drug delivery solutions, has announced that its U...
Aptar PharmaProduct InfoAptar Pharma's nasal unidose device approved for Tosymra sumatriptan sprayAptar Pharma, a leading provider of drug delivery devices worldwide and part of AptarGroup, Inc. has...
Aptar PharmaProduct InfoAptar Pharma launches eDose counter for MDIs integrating a proprietary sensing technologyAptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray deliv...
Aptar PharmaProduct InfoAptar Pharma provides unit-dose nasal spray technology for treatment of opioid overdoseAptar Pharma has announced that it has provided the delivery system and regulatory support for Adap...